Interventional Cardiology & Vascular Therapies — Net Sales
Boston Scientific Interventional Cardiology & Vascular Therapies — Net Sales remained flat by 0.0% to $1.16B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 10.5%, from $1.05B to $1.16B. Over 2 years (FY 2023 to FY 2025), Interventional Cardiology & Vascular Therapies — Net Sales shows an upward trend with a 10.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates growing adoption of the company's cardiovascular technologies and successful market expansion, while a decrease may signal increased competition, pricing pressure, or a slowdown in procedure volumes.
Detailed definition
This metric represents the total revenue generated from the sale of medical devices and technologies specifically design...
Peer comparison
Comparable to cardiovascular segment revenues reported by major medical device peers like Medtronic, Abbott, or Edwards Lifesciences, often analyzed alongside procedure volume trends.
bsx_segment_interventional_cardiology_vascular_therapies_net_salesHistorical Data
| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $3.79B | $4.20B | $4.64B |
| YoY Change | — | +10.8% | +10.5% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Boston Scientific's interventional cardiology & vascular therapies — net sales?
- Boston Scientific (BSX) reported interventional cardiology & vascular therapies — net sales of $1.16B in Q4 2025.
- How has Boston Scientific's interventional cardiology & vascular therapies — net sales changed year-over-year?
- Boston Scientific's interventional cardiology & vascular therapies — net sales increased by 10.5% year-over-year, from $1.05B to $1.16B.
- What is the long-term trend for Boston Scientific's interventional cardiology & vascular therapies — net sales?
- Over 2 years (2023 to 2025), Boston Scientific's interventional cardiology & vascular therapies — net sales has grown at a 10.6% compound annual growth rate (CAGR), from $3.79B to $4.64B.
- What does interventional cardiology & vascular therapies — net sales mean?
- The total revenue earned from selling medical devices used in heart and vascular procedures.